Ryan Potts
Vice President Amgen Inc.
Seminars
Wednesday 28th October 2026
Chair’s Opening Remarks
8:20 am
Wednesday 28th October 2026
Beyond Degraders: Are We Asking the Wrong Questions in Induced Proximity?
9:30 am
- Scalable discovery of molecular glue degraders beyond CRBN
- Protein relocalization through proximity using RELOTACs
- Restoring and reprogramming biology
Wednesday 28th October 2026
Panel Discussion: Shaping Investment in Induced Proximity: Insights to Accelerate Development & Secure Funding
10:00 am
- Exploring the data, targets, and indications investors are prioritizing to support next-generation induced proximity therapeutics
- Discussing funding strategies for early-stage companies, including milestones needed to secure investment and attract pharmaceutical partnerships
- Evaluating how scientific innovation and emerging modalities influence investor confidence and the types of assets and platforms likely to attract investor interest
